You are in: Home Page

Information for Shareholders and Investors print

Last News and Press Notes Corporate Transaction Announcement Grifols obtains FDA license in the US market for its IVIG Flebogamma® DIF 10% concentration 02.09.2010 Grifols sales in the first half of 2010 increase 3.7% up to 487.8 million Euros 29.07.2010 Grifols obtains its first crédit rating from Standard & Poor's and Moody's 20.07.2010 Progenika Biopharma grants Grifols World-wide distribution of its Bloodchip® genotyping test for blood donors 24.06.2010 Grifols holds its Annual General Meeting 21.06.2010 Grifols to acquire talecris biotherapeutics creating a world leading provider of life-saving plasma protein therapies 07.06.2010   news archive